Methyl Alcohol

Methyl Alcohol

SCHEMBL3645347

CC(OCCCN1CCC(c2noc3cc(F)ccc23)CC1)Oc1ccccc1.CO

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.61
HTR2A P28223 5/20 0.61
HTR1A P08908 4/20 0.59
KCNH2 Q12809 3/20 0.59
HTR2C P28335 2/20 0.59
ADRA1A P35348 2/20 0.59
HRH1 P35367 2/20 0.59
HTR6 P50406 2/20 0.59
ADRA2A P08913 1/20 0.59
ADRA1D P25100 1/20 0.59
ADRA1B P35368 1/20 0.59
HRH3 Q9Y5N1 3/20 0.59
DRD3 P35462 1/20 0.59
SLC6A4 P31645 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1545461 0.86 HTR1A (0.76) DRD2HTR2AHTR1AKCNH2HTR2C
Anisole SCHEMBL3645349 0.85 DRD2 (0.63) DRD2HTR2AHTR1AKCNH2HTR2C
Methyl Alcohol SCHEMBL718326 0.81 DRD2 (0.69) DRD2HTR2AHTR1AKCNH2HTR2C
Methyl Alcohol SCHEMBL718327 0.81 HTR1A (0.76) DRD2HTR2AHTR1AKCNH2HTR2C
Methyl Alcohol SCHEMBL142049 0.81 ABCB11 (0.66) DRD2HTR2AHTR1AKCNH2HTR2C
SCHEMBL8714677 0.81 HTR2A (0.62) DRD2HTR2AHTR1AKCNH2HTR2C
Methyl Alcohol SCHEMBL929693 0.80 CHRM2 (0.65) DRD2HTR2AHTR1AKCNH2HTR2C
SCHEMBL22149696 0.80 DRD2 (0.76) DRD2HTR2AHTR1AKCNH2HTR2C
Alcohol SCHEMBL8713382 0.79 HTR1A (0.69) DRD2HTR2AHTR1AKCNH2HTR2C
Alcohol SCHEMBL142048 0.79 DRD2 (0.66) DRD2HTR2AHTR1AKCNH2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2198049-A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE Vanda Pharmaceuticals Inc. (US) 2010-06-23 EP disclosed
WO-2009036056-A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE VANDA PHARMACEUTICALS, INC. (US) 2009-03-19 WO disclosed